http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012065367-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d2b2d208d980552ef2e127f0146a53b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e41eefe437d41c6b293dbdc3abd7297f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c56e69073483b7ad4d4d88282898902 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0406 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-082 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64 |
| filingDate | 2009-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f1413ab9fb07b2561eb15bd9be03e4f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc9703eba81d46b84dfe0ff59af629aa |
| publicationDate | 2012-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2012065367-A1 |
| titleOfInvention | Radioactively Labeled Substance |
| abstract | Provided are: a radiolabeled drug, which is efficiently accumulated in a target and has high in vivo stability; and diagnosis and treatment each using the radiolabeled drug. Specifically provided are: a radiolabeled drug showing increased accumulation in a target site, which comprises a complex composed of a ligand that is bound to a compound capable of binding to a target molecule and forms a polycoordinated complex with a metal (e.g., technetium or rhenium) and a radionuclide of the metal; the radiolabeled drug for diagnosis or treatment; a ligand for preparing the radiolabeled drug; a kit that comprises a drug comprising the ligand and a drug comprising a radionuclide of a metal, as separate package units; and a method of increasing accumulation of a radiolabeled drug in a target site, comprising using the above-mentioned radiolabeled drug. |
| priorityDate | 2009-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 201.